Boston, MA, United States of America

Philip A Swain

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 68(Granted Patents)


Location History:

  • Brighton, MA (US) (1998)
  • Boston, MA (US) (1998 - 2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Philip A. Swain in Drug-Abuse Therapy

Introduction: Philip A. Swain is a distinguished inventor based in Boston, MA, known for his significant contributions to the field of drug-abuse therapy. With a remarkable portfolio of five patents, Swain has dedicated his career to developing innovative solutions aimed at combating drug addiction, particularly cocaine dependency.

Latest Patents: Among his latest innovations, Swain has focused on hapten-carrier conjugates designed for use in drug-abuse therapy. These conjugates are instrumental in eliciting anti-hapten antibodies in vivo, providing a potential breakthrough in addiction treatment. His methods of preparing these hapten-carrier conjugates and associated therapeutic compositions reveal their efficacy in addressing drug addiction. Specifically, when the hapten represents a drug of abuse, these therapeutic compositions show promise as a treatment for cocaine addiction. Additionally, his work discusses the benefits of passive immunization through antibodies raised against these conjugates. The therapeutic composition is also noted to be suitable for co-therapy alongside traditional drugs, further enhancing its applicability in clinical settings.

Career Highlights: Swain's career has been marked by his tenure at prominent companies such as Immunologic Pharmaceutical Corporation and Immunologic, Inc., where he has played pivotal roles in advancing therapeutic research and development. His innovative spirit is reflected in his multiple patents, showcasing his ability to merge scientific research with practical applications in healthcare.

Collaborations: Throughout his career, Swain has collaborated with notable professionals in the field, including Victoria C. Schad and Julia L. Greenstein. These collaborations have not only enriched his research but have also helped in driving forward the understanding and treatment of drug abuse.

Conclusion: Philip A. Swain stands out as a prominent inventor in the realm of drug-abuse therapy. His latest patents underscore his commitment to developing innovative treatments for addiction, illustrating the significant impact of his work on public health. As research continues to evolve, Swain's contributions provide valuable insights and advancements in the fight against drug addiction, particularly in the realm of cocaine dependency.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…